The Center for Cardiovascular Medicine at Porter Regional Hospital has
recently employed new devices designed to treat fully blocked coronary
arteries known as Chronic Total Occlusions (CTOs).
Historically, totally blocked arteries have been addressed by heart bypass
surgery or treated with prescription drugs. The first patient of
Interventional Cardiologist Keith Atassi, M.D. was treated on June 27 using
novel techniques and technology from Boston Scientific, and was released
from the hospital the next day.
The Center for Cardiovascular Medicine at Porter Regional Hospital is the
first facility in the area to make this new line of therapy available to
According to multiple studies, 31 percent of patients referred for coronary
angiography have at least one totally blocked artery. CTOs affect the
survival and quality of life of hundreds of thousands of people, and have
historically been an untreatable condition for many patients. While some are
treated with bypass surgery, 60 percent of patients with CTOs are treated
only with prescription drugs.
The Center for Cardiovascular Medicine at Porter Regional Hospital sees
these new devices and techniques as an alternative to medical management and
a way to improve the quality of life for its patients with CTOs. The center
has established a CTO Program to address this complex form of coronary
artery disease, including in-depth physician training from Boston Scientific
on the CrossBossª and Stingrayª Coronary CTO Crossing and Re-entry System.
These devices enable physicians to treat lesions more successfully and
efficiently using minimally invasive techniques. They are currently the only
devices of their kind on the market that are FDA cleared to specifically
treat coronary CTOs.
“These unique devices require new techniques and training and we are now
among a select group of hospitals nationwide to develop these skills with
these new devices,” stated Dr. Atassi following the procedure. “Chronic
total occlusions used to have limited treatment alternatives beyond medical
management or surgery and we are pleased to be able to bring these
innovative new devices and additional treatment options to our patients and